NSAID and Paracetamol Use During Pregnancy: Risks to the Fetus
Author Information
Author(s): Katarina Dathe, Carolin Benndorf, Simone Bergner, Christof Schaefer, Gary J. Stephens, Duarte Marques Maria Matilde Soares
Primary Institution: Charité—Universitätsmedizin Berlin
Hypothesis
Do major pharmacovigilance databases support evidence of fetotoxicity from NSAID use in the second trimester and paracetamol use in the third trimester of pregnancy?
Conclusion
The study suggests that temporary use of NSAIDs in the second trimester and paracetamol in the third trimester does not pose a substantial cardiovascular or nephrotoxic risk to the fetus.
Supporting Evidence
- NSAIDs are contraindicated in the third trimester due to known risks.
- Only a small number of adverse drug reactions were reported despite widespread use of paracetamol.
- Most cases of fetotoxic effects were not assessed as likely related to the medications.
Takeaway
This study looked at how certain pain medications used during pregnancy might affect babies. It found that using these medications for a short time doesn't seem to hurt the babies much.
Methodology
The study analyzed 1288 Individual Case Safety Reports from three pharmacovigilance databases, focusing on cases with fetotoxic effects related to NSAID and paracetamol use during specific pregnancy trimesters.
Potential Biases
The analysis may be biased due to unreported or missing case information and the spontaneous nature of the reporting system.
Limitations
The study is limited by the lack of comparison cohorts, missing demographic information, and the small sample size, which makes generalization difficult.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website